Prevalence and Risk Factors for Osteopathy in Chronic Pancreatitis

Tang, Xin‐Ying; Ru, Nan; Li, Qing; Qian, Yang‐Yang; Sun, Hui; Zhu, Jiahui; He, Lin; Wang, Yuan‐Chen; Hu, Liang‐Hao; Li, Zhao‐Shen; Zou, Wenbin; Liao, Zhuan

doi:10.1007/s10620-020-06732-2

Cited by 7 publications

(1 citation statement)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…osteopenia, osteoporosis) in patients with CP ranged from 36.5% to 57.0%. 22 – 27 The observational study ‘ Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED Study) ’ was completed in 2022. A cross-sectional analysis from the PROCEED study involving 282 patients with CP showed that the prevalence of osteopathy on dual-energy X-ray absorptiometry scan was 56.0%, and higher prevalences of traumatic and spontaneous fracture were observed in the cohort of CP patients with osteopathy.…”

Section: Nutritional Supportmentioning

confidence: 99%

Management of chronic pancreatitis: recent advances and future prospects

Han,

Lv,

2024

Therap Adv Gastroenterol

Self Cite

View full text Add to dashboard Cite

As a progressive fibroinflammatory disease, chronic pancreatitis (CP) often manifests as recurrent bouts of abdominal pain with or without complications, causing a heavy burden of health care. In recent years, some meaningful insights into the management of CP have been obtained from randomized controlled trials, systematic reviews, and meta-analyses, which were of great importance. Based on this research, it is shown that there are various treatments for CP. Therefore, it is of great importance to choose a suitable strategy for patients with CP individually. Relevant evidence on the management of CP was summarized in this review, including nutrition supplements, medication, endoscopy, surgery, exploration of novel therapies as well as evaluation and prediction of treatment response.

show abstract